drugset / Trial / NCT03519061

Impact of Budesonide Irrigations on Patients With Chronic Rhinosinusitis and Impact on Sinus Surgery Rates

NCT03519061 ↗

Phase 2/3 Withdrawn Kaiser Permanente
NaSingle-groupOpen-labelTreatment

Summary

This study is intended to assess the impact of a 90 day course of high volume budesonide irrigations for patients who have failed other medical therapy and assessing the impact of the budesonide irrigations on the need for sinus surgery.

Timeline

Start
2019-08-13
Primary completion
2019-08-30
Completion
2019-10-01

Outcome

Outcome not reported

Stopped: “Unable to obtain FDA exemption”

Drugs

EvaluationDrugModalityDoseRoute
Subject Budesonide Small molecule — Intranasal